Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23937816)

1.

[Resting heart rate and cardiovascular disease].

Brito Díaz B, Alemán Sánchez JJ, Cabrera de León A.

Med Clin (Barc). 2014 Jul 7;143(1):34-8. doi: 10.1016/j.medcli.2013.05.034. Epub 2013 Aug 9. Review. Spanish.

PMID:
23937816
2.

Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight.

Curtis BM, O'Keefe JH Jr.

Mayo Clin Proc. 2002 Jan;77(1):45-54. Review.

PMID:
11794458
3.

Significance of reduction in heart rate in cardiovascular disease.

Hjalmarson A.

Clin Cardiol. 1998 Dec;21(12 Suppl 2):II3-7. Review.

PMID:
9853192
4.

Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how?

Das UN.

Prostaglandins Leukot Essent Fatty Acids. 2000 Dec;63(6):351-62. Review. Erratum in: Prostaglandins Leukot Essent Fatty Acids 2001 Jan;64(1):74.

PMID:
11133172
5.

Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?

Arnold JM, Fitchett DH, Howlett JG, Lonn EM, Tardif JC.

Can J Cardiol. 2008 May;24 Suppl A:3A-8A. Review.

6.

Goals of antihypertensive therapy.

McVeigh GE, Flack J, Grimm R.

Drugs. 1995 Feb;49(2):161-75. Review.

PMID:
7729325
7.
8.

Heart rate, autonomic markers, and cardiac mortality.

Verrier RL, Tan A.

Heart Rhythm. 2009 Nov;6(11 Suppl):S68-75. doi: 10.1016/j.hrthm.2009.07.017. Epub 2009 Sep 1. Review.

9.

Resting heart rate in cardiovascular disease.

Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M; Heart Rate Working Group.

J Am Coll Cardiol. 2007 Aug 28;50(9):823-30. Epub 2007 Aug 13. Review.

10.

Hyperinsulinemia, insulin resistance, and hypertension.

Bönner G.

J Cardiovasc Pharmacol. 1994;24 Suppl 2:S39-49. Review.

PMID:
7898093
11.
12.

Elevated heart rate in cardiovascular diseases: a target for treatment?

Palatini P.

Prog Cardiovasc Dis. 2009 Jul-Aug;52(1):46-60. doi: 10.1016/j.pcad.2009.05.005. Review.

PMID:
19615493
13.

Current treatment of patients with hypertension: therapeutic implications of INSIGHT.

Taddei S, Ghiadoni L, Salvetti A.

Drugs. 2003;63(14):1435-44. Review.

PMID:
12834362
14.

Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.

Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS.

Am J Med. 2015 Mar;128(3):219-28. doi: 10.1016/j.amjmed.2014.09.016. Epub 2014 Oct 15. Review.

PMID:
25447617
15.

[Heart rate, a major prognostic factor of cardiovascular risk].

Lévy S, Guize L.

Therapie. 2006 Mar-Apr;61(2):115-9. French.

PMID:
16886703
16.

[Can reduction in resting heart rate be beneficial for patients?].

Soucek M.

Vnitr Lek. 2007 Apr;53(4):401-3. Review. Czech.

PMID:
17578174
17.

Pharmacologic control of heart rate in atrial fibrillation.

Falk RH.

Cardiol Clin. 1996 Nov;14(4):521-36. Review.

PMID:
8950054
18.

Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.

Bangalore S, Sawhney S, Messerli FH.

J Am Coll Cardiol. 2008 Oct 28;52(18):1482-9. doi: 10.1016/j.jacc.2008.06.048.

19.

Future directions: what data do we need?

Tendera M.

Adv Cardiol. 2006;43:106-11. Review.

PMID:
16936476
20.

[Heart rate: a cardiovascular risk factor that can no longer be ignored].

Palatini P.

G Ital Cardiol (Rome). 2006 Feb;7(2):119-28. Review. Italian.

PMID:
16532723
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk